113 related articles for article (PubMed ID: 33078631)
1. Hypermethylated promoters of genes
Uhan S; Zidar N; Tomažič A; Hauptman N
Epigenomics; 2020 Oct; 12(19):1677-1688. PubMed ID: 33078631
[No Abstract] [Full Text] [Related]
2. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer.
Khalaj-Kondori M; Hosseinnejad M; Hosseinzadeh A; Behroz Sharif S; Hashemzadeh S
Curr Probl Cancer; 2020 Feb; 44(1):100471. PubMed ID: 30904169
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
5. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Dong D; Zhang R; Shao J; Zhang A; Wang Y; Zhou Y; Li Y
Clin Epigenetics; 2021 Dec; 13(1):225. PubMed ID: 34922605
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
8. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
9. UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death-associated protein kinase 1 in prostate cancer.
Dong D; Zhang L; Bai C; Ma N; Ji W; Jia L; Zhang A; Zhang P; Ren L; Zhou Y
Cancer Sci; 2019 Apr; 110(4):1244-1255. PubMed ID: 30632669
[TBL] [Abstract][Full Text] [Related]
10. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
11. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
Oster B; Thorsen K; Lamy P; Wojdacz TK; Hansen LL; Birkenkamp-Demtröder K; Sørensen KD; Laurberg S; Orntoft TF; Andersen CL
Int J Cancer; 2011 Dec; 129(12):2855-66. PubMed ID: 21400501
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
15. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
16. The expression of UNC5D is abnormal in the early stage of colorectal tumors associated with its proliferation and migration.
Shi LP; Zou C; Mao LJ; Chen TT; Xie T
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):199-213. PubMed ID: 38235871
[TBL] [Abstract][Full Text] [Related]
17. Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer.
Ye Z; Song G; Liang J; Yi S; Gao Y; Jiang H
BMC Cancer; 2023 Jul; 23(1):617. PubMed ID: 37400791
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
19. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
20. TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer.
Hrašovec S; Hauptman N; Glavač D; Jelenc F; Ravnik-Glavač M
Dis Markers; 2013; 34(2):93-104. PubMed ID: 23324576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
